On 12 August 2019, Fujian Aohua Group Co., Ltd. (“Aohua Group”) successfully issued its private convertible corporate bonds (Phase I). The private placement with a total capital scale of RMB 230 million consists of three phases, and the Phase I intends to raise an amount of RMB 130 million.
As founded on 5 April 1999, Aohua Group has been developing into a diversified comprehensive enterprise group covering pharmaceutical, medicine, investment and media sectors. It is the subsidiary of Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ).
Grandall Fuzhou Office has been retained as the issuer's legal counsel with Mr. CHEN Binggeng, Mr. ZHU Yi, and Ms. LIN Lifen servicing the client.